Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening

Journal of Cystic Fibrosis

Volumn 13, Issue 1, 2014, Pages 99-105

  Cunningham, Fiona ^a   Lewis, Sharon ^b   Curnow, Lisette ^c   Glazner, Judith ^c   Massie, John ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Attitudes; Carrier screening; Cystic fibrosis carrier screening; Genetic screening; Population screening

Indexed keywords

ARTICLE; AUSTRALIA; COPING BEHAVIOR; CYSTIC FIBROSIS; DECISION MAKING; DISEASE SEVERITY; FEAR; FEMALE; GENETIC RISK; GENETIC SCREENING; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; LAW SUIT; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PATIENT ADVOCACY; PHYSICIAN; PHYSICIAN ATTITUDE; PREGNANCY TERMINATION; PROFESSIONAL KNOWLEDGE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY PHYSICIAN;

ATTITUDES; CARRIER SCREENING; CYSTIC FIBROSIS CARRIER SCREENING; GENETIC SCREENING; POPULATION SCREENING;

ADULT; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; LOGISTIC MODELS; MALE; NEW ZEALAND; NURSE ADMINISTRATORS; PHYSICIANS; PULMONARY MEDICINE; QUESTIONNAIRES;

EID: 84890438567     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.06.009     Document Type: Article

References (30)

1. Rowe S.M., Miller S., Sorscher E.J. Mechanisms of disease: cystic fibrosis. N Eng J Med 2005, 352(19):1992-2001.
2. Elborn J.S., Shale D.J., Britton J.R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax December 1 1991, 46(12):881-885.
3. Sawyer S.M., Cerritelli B., Carter L.S., Cooke M., Glazner J.A., Massie J. Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis. Pediatrics September 1 2006, 118(3):e649-e656.
4. Massie J., Forbes R., Dusart D., Bankier A., Delatycki M.B. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. J Paediatr Child Health 2007, 43(11):721-723.
5. Chen L.-S., Goodson P. Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genet Med 2007, 9(7):442-450. [; Review].
6. McClaren B.J., Delatycki M.B., Collins V., Metcalfe S.A., Aitken M. 'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening. Eur J Hum Genet Apr. 2008, 16(4):435-444. [Epub 2007 Dec].
7. Brock D.J. Prenatal screening for cystic fibrosis: 5 years' experience. Lancet 1996, 347:148-150.
8. Locock L., Kai J. Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 2008, 58:161-168.
9. Mennie M.E., Campbell H., Liston W.A., Brock D.J. Attitudes of general practitioners to screening for cystic fibrosis. J Med Screen March 1 1998, 5(1):11-15.
10. Poppelaars F.A.M., van der Wal G., Braspenning J.C.C., Cornel M.C., Henneman L., Langendam M.W., et al. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study. Public Health 2003, 117(6):396-403. [; Research Support, Non-U.S. Gov't].
11. Castellani C., Picci L., Tamanini A., Girardi P., Rizzotti P., Assael B.M. Association between carrier screening and incidence of cystic fibrosis. JAMA December 16 2009, 302(23):2573-2579.
12. ACOG ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis. Obstet Gynecol 2005, 106(6):1465-1468. [Guideline;].
13. HGSA HGSoA Cystic fibrosis population screening position paper PP01 2009, [http://wwwhgsaorgau/2010/06/cystic-fibrosis-population-screening/].
14. Wilson J., Jungner G. Principles and practice of screening for disease. World Health Organisation Public Health Papers 1968, [34].
15. Gason A., Sheffield E., Bankier A., Aitken M., Metcalfe S., Barlow Stewart K., et al. Evaluation of a Tay-Sach's disease screening program. Clin Genet 2003, 63(5):386-392.
16. Stone C., Lester R. Genetics surveillance in Victoria: a recent review. Chief Health Off Bull 2002, 2(1):8-10.
17. Zielenski J., Tsui L.-C. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995, 29:777-807.
18. Grody W.W., Cutting G.J., Klinger K.W., Richards C.S., Watson M.S., Desnick R.J. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3(2):149-154.
19. Massie J., Petrou V., Forbes R., Curnow L., Ioannou L., Dusart D., et al. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience. Aust N Z J Obstet Gynaecol 2009, 49(5):484-489.
20. Baars M.J.H., Henneman L., ten Kate L.P. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands. Genet Test 2004, 8(4):431-436. [; Research Support, Non-U.S. Gov't].
21. Poppelaars F.A.M., Henneman L., Ader H.J., Cornel M.C., Hermens R.P.M.G., van der Wal G., et al. How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population. Community Genet 2003, 6(3):157-165. [; Research Support, Non-U.S. Gov't].
22. Rowley P.T., Loader S., Levenkron J.C., Phelps C.E. Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers. Am J Prev Med 1993, 9(5):261-266. [Comparative Study; Research Support, U.S. Gov't, P.H.S.].
23. Axworthy D., Brock D.J., Bobrow M., Marteau T.M. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet May 1996, 347(9013):1443-1446. [Comparative Study; Research Support, Non-U.S. Gov't].
24. Lakeman P., Plass A.M.C., Lidewij H., Bezemer P.D., Cornel M.C., ten Kate L.P. Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genet Med 2008, 10(11):820-830.
25. Mennie M.E., Compton M.E., Gilfillan A., Liston W.A., Pullen I., Whyte D.A., et al. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet July 1 1993, 30(7):543-548.
26. Honnor M., Zubrick S.R., Walpole I., Bower C., Goldblatt J. Population screening for cystic fibrosis in Western Australia: community response. Am J Med Genet 2000, 93:198-204.
27. Ioannou L., Massie J., Collins V., McClaren B., Delatycki M. Population-Based Genetic Screening for Cystic Fibrosis: attitudes and Outcomes. Popul Health Genomics 2010, 13:449-456.
28. Wilcken B.F., Wiley V.P., Sherry G.B., Bayliss U.B.H.A. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediatr 1995, 127(6):965-970.
29. Maxwell S., Kyne G., Molster C., Barker N., Jacqueline O., O'Leary P. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members. Genet Test Mol Biomarkers 2011, 15(3):1-6.
30. Stark Z., Massie J., McClaren B., Ioannou L., Cousens N., Lewis S., et al. Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions. Twin Res Hum Genet 2013, 16(02):601-607.